Contact

Jamie Lacey-Moreira, PressComm PR Principal & Founder

Are you ready to give your communications strategy a new perspective? The PressComm PR team works with life science and health care organizations, delivering a flexible, resource-leveraging communications program.

Please contact Jamie to let us know how we can help your organization:

Jamie Lacey-Moreira, Principal
PressComm PR, LLC
Ph: 410.299.3310
Email: jamielacey@presscommpr.com

News

September 14, 2020

GlycoT Therapeutics Grants Sublicense of Glycoengineering Technology to Daiichi Sankyo
BALTIMORE, Sept. 14, 2020 /PRNewswire/ -- GlycoT Therapeutics LLC, a UM Ventures start-up company based on intellectual property (IP) developed at the University of Maryland, Baltimore (UMB) and University of Maryland, College Park (UMCP), has executed [Read More]
September 9, 2020

BioBuzz: MaxCyte Appoints Amanda L. Murphy as CFO, Names Ron Holtz as SVP & CAO
Murphy brings a wealth of life sciences capital markets experience and deep knowledge in the enabling technologies and cell therapy sectorsHoltz to remain on the [Read More]
September 1, 2020

Cartesian Therapeutics Initiates Clinical Trial of First RNA-Engineered Cell Therapy for Acute Respiratory Distress Syndrome and COVID-19
Descartes-30 engineered to express a unique combination of DNases to eliminate neutrophil extracellular traps (NETs), a key driver of inflammation and clotting in ARDS. Gaithersburg, [Read More]

PressComm

Contact

Contact

Site Links

Social

About PressComm PR